Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.44 |
| ▸ | PPARG | P37231 | 7/20 | 0.44 |
| ▸ | PPARD | Q03181 | 7/20 | 0.44 |
| ▸ | PPARA | Q07869 | 7/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TLR2 | O60603 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | FABP4 | P15090 | 2/20 | 0.44 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.44 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2705081 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL27472559 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL31580036 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL571168 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL63622 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL2220585 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL450318 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL2349550 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL2199706 | 0.98 | CES2 (0.44) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL9955629 | 0.98 | CES2 (0.44) | CES2GPR84PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4032921-B1 | METHOD FOR PREPARING MODIFIED CONJUGATED DIENE-BASED POLYMER | LG CHEMICAL LTD (KR) | 2025-08-27 | — | — | EP | claimed |
| CN-114174354-B | Process for producing modified conjugated diene polymer | 株式会社LG化学 | 2024-10-01 | — | — | CN | claimed |
| CN-118613509-A | Process for preparing catalyst composition and process for preparing conjugated diene polymer | 株式会社LG化学 | 2024-09-06 | — | — | CN | claimed |
| CN-118613510-A | Process for preparing catalyst composition and process for preparing conjugated diene polymer | 株式会社LG化学 | 2024-09-06 | — | — | CN | claimed |
| CN-118556087-A | Process for preparing catalyst composition and process for preparing conjugated diene polymer | 株式会社LG化学 | 2024-08-27 | — | — | CN | claimed |
| CN-111344315-B | Process for preparing conjugated diene polymer by continuous polymerization | 株式会社LG化学 | 2023-04-28 | — | — | CN | claimed |
| EP-3715388-B1 | MODIFIED CONJUGATED DIENE-BASED POLYMER AND METHOD FOR PREPARING THE SAME | LG CHEMICAL LTD (KR) | 2023-04-26 | — | — | EP | claimed |
| EP-3943517-B1 | SYSTEM FOR CONTINUOUS PRODUCTION OF CONJUGATED DIENE-BASED POLYMER | LG CHEMICAL LTD (KR) | 2023-04-12 | — | — | EP | claimed |
| CN-110785444-B | Process for producing conjugated diene polymer by continuous polymerization | 株式会社LG化学 | 2022-09-06 | — | — | CN | claimed |
| CN-114174354-A | Method for preparing modified conjugated diene polymer | 株式会社LG化学 | 2022-03-11 | — | — | CN | claimed |
| CN-110785444-A | Process for producing conjugated diene polymer by continuous polymerization | 株式会社LG化学 | 2020-02-11 | — | — | CN | claimed |
| WO-2019078459-A1 | METHOD FOR PREPARING MODIFIED CONJUGATED DIENE-BASED POLYMER | 주식회사 엘지화학 | 2019-04-25 | — | — | WO | claimed |
| US-20070092466-A1 | Compositions and Methods for Treating Hair Loss Using C16-C20 Aromatic Tetrahydro Prostaglandins | DUKE UNIVERSITY (US) | 2007-04-26 | — | — | US | claimed |
| CN-114174354-B | Process for producing modified conjugated diene polymer | 株式会社LG化学 | 2024-10-01 | — | — | CN | disclosed |
| CN-118613509-A | Process for preparing catalyst composition and process for preparing conjugated diene polymer | 株式会社LG化学 | 2024-09-06 | — | — | CN | disclosed |
| CN-118613510-A | Process for preparing catalyst composition and process for preparing conjugated diene polymer | 株式会社LG化学 | 2024-09-06 | — | — | CN | disclosed |
| EP-2694463-B1 | TREATING CENTRAL NERVOUS SYSTEM TUMORS WITH COENZYME Q10 | BERG LLC (US) | 2019-09-04 | — | — | EP | disclosed |
| WO-2019078459-A1 | METHOD FOR PREPARING MODIFIED CONJUGATED DIENE-BASED POLYMER | 주식회사 엘지화학 | 2019-04-25 | — | — | WO | disclosed |
| WO-2019078653-A2 | MODIFIED CONJUGATED DIENE-BASED POLYMER AND METHOD FOR PREPARING SAME | 주식회사 엘지화학 | 2019-04-25 | — | — | WO | disclosed |
| CN-107074987-A | Modified butadiene-based polymers and modifiers for preparing the same | LG化学株式会社 | 2017-08-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070092466-A1 | Compositions and Methods for Treating Hair Loss Using C16-C20 Aromatic Tetrahydro Prostaglandins | PTGES, PTGES2, PTGS2 | CES2 3835/4885GPR84 1482/4885PPARG 200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.